Activating platinum with light: An inert platinum(IV) diazido complex trans, trans,trans-[Pt(N3)2(OH)2(py)2] becomes potently cytotoxic to cancer cells when activated by low doses of visible light
A series of trans-di-(N-heterocyclic)imine dihydroxido diazido PtIV complexes of the form trans,tran...
We report the synthesis and characterisation of the nitroxide spin-labelled photoactivatable Pt(IV) ...
Site-specific delivery and amenable activation of prodrugs are indispensible criteria for designing ...
We show by x-ray crystallography that the complex trans, trans, trans-[Pt(N-3)(2)(OH)(2)(NH3)(py)] (...
We show by x-ray crystallography that the complex trans, trans, trans-[Pt(N-3)(2)(OH)(2)(NH3)(py)] (...
SummaryA possible way to avoid dose-limiting side effects of platinum anticancer drugs is to employ ...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Photoactivatable Pt(IV) diazido complexes have unusual photobiologic properties. We show here that t...
Photoactivatable Pt(IV) diazido complexes have unusual photobiologic properties. We show here that t...
Platinum(II) complexes are currently the most widely used drugs in cancer chemotherapy. One strategy...
The synthesis and X-ray structure (as the tetrahydrate) of the platinum(IV) complex trans, trans, tr...
The synthesis and X-ray structure (as the tetrahydrate) of the platinum(IV) complex trans, trans, tr...
A series of trans-di-(N-heterocyclic)imine dihydroxido diazido PtIV complexes of the form trans,tran...
A series of trans-di-(N-heterocyclic)imine dihydroxido diazido PtIV complexes of the form trans,tran...
We report the synthesis and characterisation of the nitroxide spin-labelled photoactivatable Pt(IV) ...
Site-specific delivery and amenable activation of prodrugs are indispensible criteria for designing ...
We show by x-ray crystallography that the complex trans, trans, trans-[Pt(N-3)(2)(OH)(2)(NH3)(py)] (...
We show by x-ray crystallography that the complex trans, trans, trans-[Pt(N-3)(2)(OH)(2)(NH3)(py)] (...
SummaryA possible way to avoid dose-limiting side effects of platinum anticancer drugs is to employ ...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from p...
Photoactivatable Pt(IV) diazido complexes have unusual photobiologic properties. We show here that t...
Photoactivatable Pt(IV) diazido complexes have unusual photobiologic properties. We show here that t...
Platinum(II) complexes are currently the most widely used drugs in cancer chemotherapy. One strategy...
The synthesis and X-ray structure (as the tetrahydrate) of the platinum(IV) complex trans, trans, tr...
The synthesis and X-ray structure (as the tetrahydrate) of the platinum(IV) complex trans, trans, tr...
A series of trans-di-(N-heterocyclic)imine dihydroxido diazido PtIV complexes of the form trans,tran...
A series of trans-di-(N-heterocyclic)imine dihydroxido diazido PtIV complexes of the form trans,tran...
We report the synthesis and characterisation of the nitroxide spin-labelled photoactivatable Pt(IV) ...
Site-specific delivery and amenable activation of prodrugs are indispensible criteria for designing ...
DOI
Add to ORKG